Torrent Pharmaceuticals Ltd Share Price – NSE  /  BSE

Pharmaceuticals, Mid Cap

Torrent Pharmaceuticals Ltd gained for a third straight session today. The stock is quoting at Rs 2690.45, up 2.01% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.37% on the day, quoting at 22450.85. The Sensex is at 74033.44, up 0.4%. Torrent Pharmaceuticals Ltd has risen around 4.67% in last one month.

Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has risen around 1.06% in last one month and is currently quoting at 18463.75, up 0.79% on the day. The volume in the stock stood at 1.6 lakh shares today, compared to the daily average of 2.54 lakh shares in last one month.

The benchmark April futures contract for the stock is quoting at Rs 2684.05, up 1.66% on the day. Torrent Pharmaceuticals Ltd is up 63.82% in last one year as compared to a 26.35% spurt in NIFTY and a 49.4% spurt in the Nifty Pharma index.

The PE of the stock is 76.53 based on TTM earnings ending December 23.

Powered by Capital Market - Live News

Torrent Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 2574, up 0.14% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.7% on the day, quoting at 22159.1. The Sensex is at 73016.66, up 0.75%. Torrent Pharmaceuticals Ltd has slipped around 1.5% in last one month.

Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has slipped around 0.35% in last one month and is currently quoting at 18809.45, up 0.35% on the day. The volume in the stock stood at 80685 shares today, compared to the daily average of 3.15 lakh shares in last one month.

The benchmark March futures contract for the stock is quoting at Rs 2584.4, up 0.16% on the day. Torrent Pharmaceuticals Ltd is up 66.72% in last one year as compared to a 30.72% jump in NIFTY and a 58.98% jump in the Nifty Pharma index.

The PE of the stock is 74.59 based on TTM earnings ending December 23.

Powered by Capital Market - Live News

The US Food & Drug Administration (USFDA) conducted a pre-approval inspection at Torrent Pharma’s oral-oncology manufacturing facility located at Bileshwarpura in Gujarat from 5 December 2023 to 11 December 2023.

On 12 December, the firm stated that USFDA had issued a Form 483 with 5 procedural observations, post inspection. There was no observation related to data integrity reported, stated the company.

Torrent Pharma has now informed that USFDA has issued an EIR for Bileshwarpura manufacturing facility and the inspection has now been successfully closed by the USFDA.

Torrent Pharmaceuticals is the flagship company of the Torrent Group. It is ranked 6th in the Indian Pharmaceuticals Market and is amongst the top five in the therapeutics segments of cardiovascular (CV), gastro intestinal (GI), central nervous system (CNS), vitamins minerals nutritional (VMN) and cosmo-dermatology.

The company’s consolidated net profit surged 51.71% to Rs 443 crore on 9.67% rise in revenue from operations to Rs 2,732 crore in Q3 FY24 over Q3 FY23.

The scrip rose 0.11% to currently trade at Rs 2,659.20 on the BSE.

Powered by Capital Market - Live News

Torrent Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 2 February 2024, inter alia, have recommended the interim dividend of Rs 22 per equity Share (i.e. 440%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News